Nth Exception introduces AI tool for ISO 20022 adoption


Share post:

The London-based fintech Nth Exception has introduced Nucleus, a data fabric powered by machine learning designed to facilitate the ISO 20022 adoption of financial institutions.

Nucleus will use AI to help financial institutions switch to ISO 20022 and restructure operations and payments systems. Other features of Nucleus include pre-validating payee account information for international payments, validating LEIs, and automating remittance data. The tool is in line with Swift initiatives and the Bank of International Settlements’ commitment to adopting ISO 20022.

To test Nucleus’ compliance potential, Nth Exception has invited financial institutions to collaborate on proof-of-concept projects.

Read More: Nth Exception launches AI tool for ISO 20022 adoption

TalkFintech Bureau
TalkFintech Bureauhttps://talkfintech.com
TalkFintech is focused on the latest financial sector technologies and tools- covering all tech used by banks, investors, insurance, and wealth management sectors- and also conversations on retail financial management tools.


Please enter your comment!
Please enter your name here


Related articles

BNP Paribas and Ant International Partner To Improve Cross-Border Payment Solutions In Europe

BNP Paribas, a bank in the European Union, has partnered with Ant International, a digital payments and financial...

Wirex And Visa Collaborate To Promote Use Of Digital Currencies In The UK And The European Economic Area (EEA)

Wirex, a Web3 money app, and Visa, a leader in digital payments, have announced a partnership to promote...

Transend Partners With Midland States Bank To Offer Innovative POS Solutions

Transend, a company that offers working capital solutions to businesses, has announced a new partnership with Midland States...

Three in ten adults have been a victim of financial fraud; spurring industry to continue investment to protect consumers

As fraud rates continue to rise, nearly all adults in the UK (94%) now say they are taking...